Evidence map›Paper›PMID 22879370›Full record

ArticleCirculation2012

Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia.

Franca Orsini, Pia Villa, Sara Parrella, Rosalia Zangari, Elisa R Zanier, Raffaella Gesuete, Matteo Stravalaci, Stefano Fumagalli, Roberta Ottria, José J Reina and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 133 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Metabolome Wide Mendelian Randomization Assessing the Causal Relationship Between Serum Metabolites, Cerebrospinal Metabolites, and Aneurysmal Subarachnoid Hemorrhage.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Candidate neuroinflammatory markers of cerebral autoregulation dysfunction in human acute brain injury.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Review
  16. Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Franca OrsiniNeuroscience Department, University of Milan.
Pia Villa
Sara Parrella
Rosalia Zangari
Elisa R Zanier
Raffaella Gesuete
Matteo Stravalaci
Stefano Fumagalli
Roberta Ottria
José J Reina
Alessandra Paladini
Edoardo Micotti
Renato Ribeiro-Viana
Javier Rojo
Vasile I Pavlov
Gregory L Stahl
Anna Bernardi
Marco Gobbi
Maria-Grazia De Simoni
University of Milan · ITUniversity of Siena · ITBrigham and Women's Hospital · USNeuroscience Institute · IT

Funding

MECHANISMS OF COMPLEMENT INDUCED ENDOTHELIAL DYSFUNCTIONR01HL056086 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI STAHL, GREGORY L · 1996 to 2014
$5.0M
Innate Immunity and Cardiovascular FunctionR01AI089781 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI STAHL, GREGORY L · 2012 to 2016
$2.8M
Innate Immunity, Biomarkers and Myocardial InfarctionRC1HL099130 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI STAHL, GREGORY L · 2009 to 2010
$992k
Innate Immunity and Cardiovascular FunctionR56AI089781 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI STAHL, GREGORY L · 2010 to 2010
$556k
Mechanisms of complement induced endothelial dysfunctionR56HL056086 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI STAHL, GREGORY L · 2009 to 2009
$445k
NHLBI NIH HHS HL056086NHLBI NIH HHS HL099130NHLBI NIH HHS R01 HL056086NHLBI NIH HHS R56 HL056086NHLBI NIH HHS RC1 HL099130NIAID NIH HHS AI089781NIAID NIH HHS R01 AI089781NIAID NIH HHS R56 AI089781
6 · The paper itself

Abstract

backgroundThe involvement of the complement system in brain injury has been scarcely investigated. Here, we document the pivotal role of mannose-binding lectin (MBL), one of the recognition molecules of the lectin complement pathway, in brain ischemic injury. METHODS AND

resultsFocal cerebral ischemia was induced in mice (by permanent or transient middle cerebral artery occlusion) and rats (by 3-vessel occlusion). We first observed that MBL is deposited on ischemic vessels up to 48 hours after injury and that functional MBL/MBL-associated serine protease 2 complexes are increased. Next, we demonstrated that (1) MBL(-/-) mice are protected from both transient and permanent ischemic injury; (2) Polyman2, the newly synthesized mannosylated molecule selected for its binding to MBL, improves neurological deficits and infarct volume when given up to 24 hours after ischemia in mice; (3) anti-MBL-A antibody improves neurological deficits and infarct volume when given up to 18 hours after ischemia, as assessed after 28 days in rats.

conclusionsOur data show an important role for MBL in the pathogenesis of brain ischemic injury and provide a strong support to the concept that MBL inhibition may be a relevant therapeutic target in humans, one with a wide therapeutic window of application.

Indexed as

AnimalsAntibodies, MonoclonalBrain EdemaBrain IschemiaDisease Models, AnimalHumansInfarction, Middle Cerebral ArteryMaleMannansMannose-Binding LectinMiceMice, Inbred C57BLMice, Mutant StrainsRatsRats, Inbred StrainsAntibodies, MonoclonalMannansMannose-Binding Lectinmannose binding protein Apolymannose

Identifiers

PMID22879370
PMCPMC3478764
OpenAlexW1978053766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.